However, similar to what was observed in our study, in a study conducted in Northern Brazil (state of Amazonas), no differences were observed between the survival curves of PC patients with p16INK4a overexpression (log-rank p = 0.753) or molecular HPV positivity (log-rank p = 0.979) [73]. This evidence concerns the gene CDKN2A and pachyonychia congenita.